These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 18411774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM, Hong JH, Choi HY.
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [Abstract] [Full Text] [Related]

  • 3. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A, Walter B, Rogenhofer S, Wieland WF.
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ, Murphy DG, Zakri R, Cahill DJ.
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [Abstract] [Full Text] [Related]

  • 7. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, Bach T, Ganzer R.
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
    Aliaev IuG, Krupinov GE, Bezrukov EA, Grigorian VA, Amosov AV, Chalyĭ ME, Kobzev DN, Bruk IuF, Shestiperov PA.
    Urologiia; 2007 May; (6):39-44. PubMed ID: 18649659
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
    Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.
    Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
    [Abstract] [Full Text] [Related]

  • 12. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
    Inoue Y, Goto K, Hayashi T, Hayashi M.
    Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
    [Abstract] [Full Text] [Related]

  • 13. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J, Chen ZY, Wang W, Zhang YF, Qiu XF, Zhang LC, Hu WL, Xu WF, Ye ZQ.
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [Abstract] [Full Text] [Related]

  • 14. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
    Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y.
    J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
    [Abstract] [Full Text] [Related]

  • 15. Control of prostate cancer by transrectal HIFU in 227 patients.
    Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X, Dubernard JM, Gelet A.
    Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
    [Abstract] [Full Text] [Related]

  • 16. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
    Poissonnier L, Gelet A, Chapelon JY, Bouvier R, Rouviere O, Pangaud C, Lyonnet D, Dubernard JM.
    Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
    [Abstract] [Full Text] [Related]

  • 17. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S, Chaussy C.
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [Abstract] [Full Text] [Related]

  • 18. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.
    Ripert T, Azémar MD, Ménard J, Bayoud Y, Messaoudi R, Duval F, Staerman F.
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):132-7. PubMed ID: 20048758
    [Abstract] [Full Text] [Related]

  • 19. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
    Uchida T, Illing RO, Cathcart PJ, Emberton M.
    BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
    [Abstract] [Full Text] [Related]

  • 20. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS, Barkin J, Radomski SB, Fleshner NE, Liu B, Bensimon K, Arora S, Robinette M, Finelli A.
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.